CD200R1 and head and neck squamous cell carcinoma: More recent findings in another human xenograft model of head and neck cancers [96] showed that in mice transplanted with head and neck squamous cell carcinoma (HNSCC), cells overexpressing CD200 had attenuated tumor growth when treated with adenovirus-expressing soluble CD200R-Ig.